Viral Hepatitis: From Pathophysiology to Therapeutic Approaches
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 924
Special Issue Editor
Special Issue Information
Dear Colleagues,
Viral hepatitis remains a leading global cause of liver disease, cancer, and mortality, despite major advances in prevention and treatment. This Special Issue aims to bring together current research and emerging insights that deepen our understanding of viral pathogenesis and host–virus interactions, while highlighting new diagnostic, therapeutic, and preventive strategies. We invite contributions focusing on all major hepatotropic viruses, including HBV, HCV, HDV, and HEV, as well as relevant model systems and comparative studies. Topics of interest include mechanisms of viral persistence, immune evasion, and liver injury; development of antiviral resistance; host genetic and immunologic determinants of disease outcome; and advances in vaccines, antiviral agents, and immunomodulatory therapies. We also welcome translational and clinical studies exploring biomarkers, treatment optimization, and viral co-infections in special populations. By integrating mechanistic, translational, and clinical perspectives, this collection seeks to inform future strategies for achieving global hepatitis elimination and improving patient care.
Dr. Manish C. Choudhary
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral hepatitis
- hepatotropic viruses
- viral persistence
- immunomodulatory
- antiviral resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
